Yes 81306 A TAR for CPT code 81306 requires documentation of the following criteria: NUDT15 hydrolase 15) any gene analysis, common The patient is undergoing thiopurine therapy, provider, variant(s) and except with The patient has severe or prolonged valid TAR myelosuppression. override No One of the following ICD-10-CM codes is required 81310 on the claim: NPM1 (nucleophosmin) any gene analysis, exon 12 C92.00 C92.02 – provider, variants except with valid TAR override No One of the following ICD-10-CM codes is required on the claim: NRAS (neuroblastoma RAS any C18.0, C18.2 C20, D01.1, D01.2, D01.40, D01.49, viral [v-ras] oncogene – provider, homolog) gene analysis, D37.4 or D37.5 except with variants in exon 2 and exon valid TAR 3 override Yes 81312 A TAR for CPT code requires documentation of the following criteria: PABPN1 (poly[A] binding any protein nuclear 1) gene The patient has symptoms of ptosis and provider, analysis, evaluation to dysphagia, and except with detect abnormal alleles The patient requires the service as a confirmatory valid TAR test for Oculopharyngeal Muscular Dystrophy override 81314 No ICD-10-CM code D48.1 is required on the PDGFRA any (platelet-derived growth provider, factor receptor, alpha except with polypeptide), gene analysis, valid TAR targeted sequence analysis override
81306 NUDT15 hydrolase 15) gene analysis, common variant(s) Yes A TAR for CPT code 81306 requires documentation of the following criteria: The patient is undergoing thiopurine therapy, and The patient has severe or prolonged myelosuppression. any provider, except with valid TAR override 81310 NPM1 (nucleophosmin) gene analysis, exon 12 variants No One of the following ICD-10-CM codes is required on the claim: C92.00 – C92.02 any provider, except with valid TAR override NRAS (neuroblastoma RAS viral [v-ras] oncogene homolog) gene analysis, variants in exon 2 and exon 3 No One of the following ICD-10-CM codes is required on the claim: C18.0, C18.2 – C20, D01.1, D01.2, D01.40, D01.49, D37.4 or D37.5 any provider, except with valid TAR override 81312 PABPN1 (poly[A] binding protein nuclear 1) gene analysis, evaluation to detect abnormal alleles Yes A TAR for CPT code requires documentation of the following criteria: The patient has symptoms of ptosis and dysphagia, and The patient requires the service as a confirmatory test for Oculopharyngeal Muscular Dystrophy any provider, except with valid TAR override 81314 PDGFRA (platelet-derived growth factor receptor, alpha polypeptide), gene analysis, targeted sequence analysis No ICD-10-CM code D48.1 is required on the any provider, except with valid TAR override